Company · CIK 0001776985 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
BioNTech SE · BNTX
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 SForm 4 → | Sep 24, 4:26 pm EDT | Ugur SahinChief Executive Officer, 10% Owner | 69,000 | $99.17 | $6,842,742 | 341,209 | −16.8% | 10b5-1 |
| Sep 21, 2026 SForm 4 → | Sep 22, 5:04 pm EDT | Ugur SahinChief Executive Officer, 10% Owner | 79,000 | $99.50 | $7,860,757 | 410,209 | −16.1% | 10b5-1 |
| Sep 17, 2026 SForm 4 → | Sep 18, 4:41 pm EDT | Ugur SahinChief Executive Officer, 10% Owner | 64,000 | $97.49 | $6,239,071 | 489,209 | −11.6% | 10b5-1 |
| Sep 15, 2026 SForm 4 → | Sep 16, 4:46 pm EDT | Ugur SahinChief Executive Officer, 10% Owner | 49,000 | $96.37 | $4,721,976 | 553,209 | −8.14% | 10b5-1 |
| Sep 11, 2026 SForm 4 → | Sep 14, 4:50 pm EDT | Ugur SahinChief Executive Officer, 10% Owner | 86,000 | $98.13 | $8,439,336 | 602,209 | −12.5% | 10b5-1 |
| Sep 10, 2026 SForm 4 → | Sep 11, 5:18 pm EDT | Ugur SahinChief Executive Officer, 10% Owner | 20,500 | $96.31 | $1,974,287 | 688,209 | −2.89% | 10b5-1 |
| Sep 8, 2026 SForm 4 → | Sep 9, 5:29 pm EDT | Ugur SahinChief Executive Officer, 10% Owner | 73,000 | $98.50 | $7,190,663 | 708,709 | −9.34% | 10b5-1 |
| Sep 3, 2026 SForm 4 → | Sep 8, 4:10 pm EDT | Ugur SahinChief Executive Officer, 10% Owner | 76,500 | $103.12 | $7,889,055 | 781,709 | −8.91% | 10b5-1 |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.